It is a chemicals private limited company based in Poonamallee, Tamil Nadu, India, established in 2010.
2010 | Poonamallee, Tamil Nadu, India | ActivePraval Pharmaceuticals Private Limited, a active private limited company, was established on 17 February 2010 in Poonamallee, Tamil Nadu, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U74900TN2010PTC074625. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Krishnamurthy Ravisankar (Director), Sivakumar Natarajan (Director). Past directors included Subramanian Sumathi, Sivakumar Natarajan. It holds ₹0.78 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mahindra Happinest, G-9, 5Th Cross St., Vgn Royal Avenue Extn., Poonamallee Avadi High Road, Poonamallee, Tamil Nadu, 600071.
U74900TN2010PTC074625
074625
17 February 2010
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Praval Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnamurthy Ravisankar | Director | 17 Feb 2010 | Current |
| Sivakumar Natarajan | Director | 04 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 May 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Praval Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 19.83% decrease. The company also saw a substantial fall in profitability, with a 46.59% decrease in profit. The company's net worth moved up by a moderate rise of 7.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Praval Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹782,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2019 | Others | ₹0.78 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Praval Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Praval Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Praval Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Praval Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Praval Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
A charge with Others of Rs. 0.78 M registered on 04 Jun 2019 with Charge ID 100266299 was modified on 30 Jun 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.78 M with Charge ID 100266299 was registered on 04 Jun 2019. was completed.
Progress on Sivakumar Natarajan was appointed as a Director was appointed as a Director on 04 May 2012 & has been associated with this company since 13 years 7 months . was documented.
The activity Krishnamurthy Ravisankar was appointed as a Director was appointed as a Director on 17 Feb 2010 & has been associated with this company since 15 years 10 months . was completed.
The CIN of Praval Pharmaceuticals Private Limited is U74900TN2010PTC074625.
Praval Pharmaceuticals Private Limited is headquartered at Mahindra Happinest, G-9, 5Th Cross St., Vgn Royal Avenue Extn., Poonamallee Avadi High Road, Poonamallee, Tamil Nadu, 600071.
Praval Pharmaceuticals Private Limited was incorporated on 17 February 2010.
The current directors of Praval Pharmaceuticals Private Limited are
The primary industry of Praval Pharmaceuticals Private Limited is Manufacturing.
Praval Pharmaceuticals Private Limited is unlisted.
The authorized capital of Praval Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Praval Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX